AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Hixita-M 50 Tablet

Prescription Icon
Prescription Required

Marketer

Hicxica Formulations Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Hixita-M 50 Tablet

Combiflex-D 50mg tablets combine two active ingredients to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lessening the risk of cardiovascular events. Combiflex-D 50mg may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, glucose levels, and other medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under physician guidance. Adherence to your prescribed diet and exercise plan is crucial for effective diabetes management, as lifestyle significantly impacts blood sugar control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Low blood sugar (hypoglycemia) is a potential risk, especially when combined with insulin or sulfonylureas; understanding hypoglycemia recognition and management is essential. This medication isn't universally suitable. Inform your physician of any pre-existing kidney, liver, heart, or pancreatic conditions, or excessive alcohol consumption before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Concurrent medications may interact with Combiflex-D 50mg; disclose all medications to ensure safety. Alcohol should be limited due to its hypoglycemic effects. Your doctor will monitor renal function and blood glucose levels throughout treatment.

Uses of Hixita-M 50 Tablet

Managing type 2 diabetes

Major Benefits of Hixita-M 50 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or divide it. Hixita-M 50mg tablets should be administered with food.

Common Side effects of Hixita-M 50 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Hixita-M 50 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Hixita-M 50 Tablet whole; do not chew, crush, or fracture it. Administer this medicine with a meal.

How Hixita-M 50 Tablet works:

Hixita-M 50 Tablets combine sitagliptin and metformin to manage blood sugar. Sitagliptin boosts insulin production by the pancreas, enhances insulin effectiveness, and diminishes excess liver glucose. Metformin, a biguanide, reduces liver glucose output, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action achieves superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Hixita-M 50 Tablets; doing so is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Hixita-M 50 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the unborn child. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Hixita-M 50 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Hixita-M 50 Tablet cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult a physician. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The use of Hixita-M 50 Tablet is potentially hazardous for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Hixita-M 50 Tablet :

Should you forget a Hixita-M 50 Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Hixita-M 50 Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Hixita-M 50 Tablet

Hixita-M 50 Tablet combines sitagliptin and metformin to treat type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged Hixita-M 50 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia and neurological issues, including tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Hixita-M 50 Tablet may cause common side effects including low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are possible. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Hixita-M 50 Tablet components or excipients, or those experiencing severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Hixita-M 50 Tablet and alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Hixita-M 50 Tablet can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as MALA—Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Hixita-M 50 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Hixita-M 50 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Hixita-M 50 Tablet is contraindicated in patients with known hypersensitivity to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Hixita-M 50 Tablet and alcohol is unsafe and may heighten the risk of lactic acidosis.
Hixita-M 50 Tablet can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Hixita-M 50 Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Hixita-M 50 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. It helps control blood sugar levels when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18 years of age.
Hixita-M 50 Tablet may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Hixita-M 50 Tablet is contraindicated in patients with hypersensitivity to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Hixita-M 50 Tablet and alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency marked by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Hixita-M 50 Tablet. This rare complication is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol, hence its avoidance in such groups. Symptoms can include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should you experience these, discontinue Sitagliptin + Metformin immediately and seek urgent medical attention.
Prolonged Hixita-M 50 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia and neurological issues, including numbness, tingling in extremities, weakness, urinary difficulties, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Hixita-M 50 Tablet
85
MRP 99
14% off